Euroasian journal of hepato-gastroenterology

Register      Login

VOLUME 6 , ISSUE 2 ( July-December, 2016 ) > List of Articles


Nonalcoholic Fatty Liver Disease in South Asia

Girish K Pati, Shivaram P Singh

Citation Information : K Pati G, P Singh S. Nonalcoholic Fatty Liver Disease in South Asia. Euroasian J Hepatogastroenterol 2016; 6 (2):154-162.

DOI: 10.5005/jp-journals-10018-1189

License: CC BY-NC 4.0

Published Online: 01-05-2010

Copyright Statement:  Copyright © 2016; The Author(s).


Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the West, and is also increasing alarmingly in South Asia, reaching an epidemic proportion of 30% because of epidemic of obesity and metabolic syndrome (MS) in younger South Asians in the last two decades. Prevalence of MS and fatty liver is escalating in geometric progression in South Asian countries, such as India, Pakistan, Sri Lanka, Bangladesh, Nepal, Bhutan, Burma, and Maldives because of sedentary lifestyle, poor health awareness, socioeconomic growth, affluence, urbanization, and dietary westernization. Almost 20% of world’s population resides in South Asia, making it the most populous and most densely populated geographic region in the world, thereby having most of MS and NAFLD cases within its territory. The risk factors and course of NAFLD do not differ between South Asians and other ethnic populations, but the obesity epidemic is more recent in South Asia than elsewhere in the world. Nonalcoholic fatty liver disease may progress through stages of simple bland steatosis, nonalcoholic steatohepatitis (NASH), hepatic fibrosis, cirrhosis, and finally hepatocellular carcinoma (HCC). It is frequently associated with obesity, MS, dyslipidemia, insulin resistance (IR), and type-2 diabetes mellitus (DM). Nonalcoholic fatty liver disease is frequently diagnosed with abdominal ultrasonography (US) study. Despite its high prevalence in the community till now, no definitive pharmacotherapy is available for NAFLD. However, modification of risk factors, such as dyslipidemia, control of diabetes, and weight reduction do help to some extent. The nonobese South Asians are also at increased risk of having NAFLD and NASH as, despite of absence of frank obesity in South Asians, they are metabolically more obese compared to other ethnic population and more prone to develop NAFLD-related complications. Therefore, the cost-effective US abdomen should be included in the list of tests for persons undergoing preemployment or master health checkups for early diagnosis of NAFLD in this resource-constraint South Asian region, so that early necessary measures can be undertaken to reduce NAFLD associated morbidity and mortality in the community.

PDF Share
  1. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980 Jul;55(7):434-438
  2. Nonalcoholic steatohepatitis and the metabolic syndrome. Am J Med Sci 2005 Dec;330(6):326-335
  3. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003 Apr;37(4):917-923
  4. Managing nonalcoholic fatty liver disease: recommendations for family physicians. Can Fam Physician 2007 May;53(5):857-863
  5. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004 Dec;40(6):1387-1395
  6. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2007 Apr 15;25(18):883-889
  7. Communitybased interventions to promote blood pressure control in a developing country: a cluster randomized trial. Ann Intern Med 2009 Nov 3;151(9):593-601
  8. Modification of the relationship between simple anthropometric indices and risk factors by ethnic background. Metabolism 2003 Oct;52(10):1295-1301
  9. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005 Nov 15;143(10):722-728
  10. American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002 Nov;123(5):1705-1725
  11. The epidemiology and risk factors of NASH. In: Farrell GC, George J, de la Hall P, McCullough AJ, editors. Fatty liver disease: NASH and related disorders. Malden (MA): Blackwell Publishing; 2005. p. 23-37
  12. Insulin resistance and C reactive protein as independent risk factors for non alcoholic fatty liver disease in non-obese Asian men. J Gastroenterol Hepatol 2004 Jun;19(6):694-698
  13. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 2004 Aug;19(8):854-858
  14. Prevalence of non-alcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J Gastroenterol 2003 May;9(5):1106-1110
  15. Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians. World J Gastroenterol 2006 Jun 7;12(21):3400-3405
  16. Pathogenesis and management issues for nonalcoholic fatty liver disease. World J Gastroenterol 2007 Sep 14;13(34):4539-4550
  17. The gut-liver-axis: endotoxemia, inflammation, insulin resistance and NASH. J Hepatol 2008 Jun;48(6):1032-1034
  18. Nonalcoholic fatty liver disease. N Engl J Med 2002 Apr 18;346(16):1221-1231
  19. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 2007 Jun;22(6):775-777
  20. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007 Dec;102(12):2708-2715
  21. Nonalcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol 2007 Jun;22(6):778-787
  22. Fitness versus fatness: moving beyond weight loss in nonalcoholic fatty liver disease. Hepatology 2010 Jul;52(1):370-381
  23. Treatment of non-alcoholic fatty liver disease. Postgrad Medl J 2006 May;82(967):315-322
  24. Treatment of nonalcoholic fatty liver: present and emerging therapies. Semin Liver Dis 2001;21(1):81-88
  25. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years. J Gastroenterol Hepatol 2007 Apr;22(4):510-514
  26. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology 2009 Aug;137(2):532-540
  27. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991 Feb 16;337(8738):382-386
  28. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res Clin Pract 2009 Apr;84(1):84-91
  29. Non obese population in a developing country has a high prevalence of non-alcoholic fatty liver and significant liver disease. Hepatology 2010 May;51(5):1593-1602
  30. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population. J Gastroenterol Hepatol 2009 Jul;24(7):1284-1288
  31. Nonalcoholic fatty liver disease in a rural, physically active, low income population in Sri Lanka. BMC Res Notes 2011 Nov 24;4:513
  32. Body composition, visceral fat, leptin and insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999 Jan;84(1):137-144. Nonalcoholic Fatty Liver Disease in South Asia Euroasian Journal of Hepato-Gastroenterology, July-December 2016;6(2):154-162 161 EJOHG 33. Liu CJ. Prevalence and risk factors for NAFLD in Asian people who are not obese. J Gastroenterol Hepatol 2012 Oct;27(10):1555-1560
  33. Relationship of glucose intolerance and hyperinsulinaemia to body fat pattern in South Asians and Europeans. Diabetologia 1992 Aug;35(8):785-791
  34. Body composition and the metabolic syndrome in Asian Indians: a saga of multiple adversities. Natl Med J India 2003 Jan-Feb;16(1):3-7
  35. Nonobese hyperlipidemic Asian northern Indian males have adverse anthropometric profile. Nutr Metab Cardiovasc Dis 2002 Aug;12(4):178-183
  36. Serum immunoreactive insulin responses to a glucose load in Asian Indian and European type 2 (noninsulin- dependent) diabetic patients and control subjects. Diabetologia 1986 Apr;29(4):235-237
  37. Insulin resistance in patients of Asian Indian and European origin with non-insulin dependent diabetes. Horm Metab Res 1987 Feb;19(2):84-85
  38. Cardiovascular disease risk factors in 2 distinct ethnic groups: Indian and Pakistani compared with American premenopausal women. Am J Clin Nutr 1999 Apr;69(4):621-631
  39. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 2005 Feb;41(2):372-379
  40. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci USA 2006 Nov 28;103(48):1827-1837
  41. Impact of ethnicity on body fat patterning in Asian Indians and Blacks: relationship with insulin resistance. Nutrition 2003 Sep;19(9):815-816
  42. High prevalence of insulin resistance in postpubertal Asian Indian children is associated with adverse truncal body fat patterning, abdominal adiposity and excess body fat. Int J Obes Relat Metab Disord 2004 Oct;28(10):1217-1226
  43. Adiposity and hyperinsulinemia in Indians are present at birth. J Clin Endocrinol Metab 2002 Dec;87(12):5575-5580
  44. Relationship of Xba1 and EcoR1 polymorphisms of apolipoprotein- B gene to dyslipidemia and obesity in Asian Indians in North India. Indian Heart J 2001 Mar-Apr;53(2):177-183
  45. Apolipoprotein B gene polymorphisms are associated with lipid levels in men of South Asian descent. Atherosclerosis 1991 Dec;91(3):267-275
  46. Prevalence of the APOC3 promoter polymorphisms T-455C and C-482T in Asian-Indians. Am J Cardiol 2001 Jan 15;87(2):220-221, A8
  47. DNA polymorphisms of the apolipoprotein B gene are associated with obesity and serum lipids in healthy Indians in Singapore. Clin Genet 1993 Sep;44(3):113-120
  48. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008 Nov;93 (11 Suppl 1):S9-S30
  49. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999 Jul;84(7):2329-2335
  50. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 2001 Nov;86(11): 5366-5371
  51. Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications. Nutrition 2004 May;20(5):482-491
  52. The metabolic syndrome in Asian Indians: the impact of nutritional and socioeconomic transition in India. Metab Syndr Relat Disord 2004 Spring;2(1):14-23
  53. Relationship of hyperinsulinemia to dietary intake in South Asian European men. Am J Clin Nutr 1994 May;59(5):1069-1074
  54. Heritability of nonalcoholic fatty liver disease. Gastroenterology 2009 May;136(5):1585-1592
  55. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999 Jun;116(6):1413-1419
  56. A clinical and biochemical profile of biopsy-proven non-alcoholic fatty liver disease subjects. J Coll Physicians Surg Pak 2007 Sep;17(9):531-534
  57. The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West. Dig Dis Sci 2007 Sep;52(9):2368-2374
  58. Novel phenotypic markers and screening score for the metabolic syndrome in adult Asian Indians. Diabetes Res Clin Pract 2008 Feb;79(2):e1-e5
  59. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention. Metab Syndr Relat Disord 2009 Dec;7(6):497-514
  60. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation 2001 Jul 10;104(2):145-150
  61. Nonalcoholic fatty liver disease of two ethnic groups in Kuwait: comparison of prevalence and risk factors. Med Princ Pract 2012;21(1):56-62
  62. The metabolic syndrome in South Asians: continuing escalation & possible solutions. Indian J Med Res 2007 Mar;125(3):345-354
  63. Insulin resistance syndrome (metabolic syndrome) and Asian Indians. Curr Sci 2002 Dec 25;83(12):1483-1496
  64. Nonalcoholic steatohepatitis: our experience. Indian J Gastroenterol 2004;23(Suppl 1):S25.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.